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Haemosiderin iron cores isolated from patients with secondary haemochromatosis have a goethite-like (a-FeOOH) crystal 
structure whereas those from patients with primary haemochromatosis are amorphous Fe (III) oxide. Haemosiderin cores 
isolated from normal human spleen are crystalline ferrihydrite (SFe,O, .9H,O). The disease-specific structures are signifi- 
cantly different from the ferrihydrite structure of associated ferritin cores. The results are important in understanding 
the biological processing of iron in pathological states and in the clinical treatment of iron-overload diseases, 
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1. INTRODUCTION 
The iron storage proteins, ferritin and 
haemosiderin, consist of a non-haem iron complex 
associated with multiple polypeptides. Whereas 
both the iron complex and the protein constituents 
of ferritin have been extensively studied [ 1,2], the 
chemical and structural nature of haemosiderin re- 
mains to be determined even though this protein is 
of fundamental importance in various iron- 
overload diseases [3]. We report here, for the first 
time, the structural identification of the 
haemosiderin iron cores isolated from patients 
with primary (PH) (idiopathic haemochromatosis) 
and secondary haemochromatosis (SH) due to ,8- 
thalassemia treated by multiple transfusions. Our 
results show that the structure of the haemosiderin 
iron complexes is disease-specific and different 
from the ferrihydrite (5FezOs. 9H20) structure of 
associated ferritin cores. These results are impor- 
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tant in understanding the biochemical mechanisms 
of iron processing in pathological states and in the 
clinical treatment of these diseases. 
2. EXPERIMENTAL 
Haemosiderin was isolated from two patient samples of PH 
iron-overloaded liver and from the livers or spleens of three pa- 
tients with SH using methods described [5]. Ferritin was 
isolated from these tissues by conventional procedures [6]. Elec- 
tron microscopy and selected area electron diffraction were 
undertaken using a Jeol 2000FX transmission electron 
microscope operating at 200 keV. “Fe Mossbauer spectra were 
recorded on a conventional constant acceleration spectrometer 
using a “Co in rhodium source. Protein and iron concentra- 
tions were determined by the method of Lowry et al. [12] and 
by flameless atomic absorption spectroscopy, respectively. Pep- 
tide analysis was undertaken using SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE). The solubility of the iron cores in 
the presence of oxalate was determined by dialysis of matched 
Fe concentrations (80pmoWl) against 0.2 M ammonium ox- 
slate/oxalic acid at pH 3.0 and 25°C. The rate of Fe dissolution 
was determined by assaying the iron in the dialysate after 
various times by electrothermal atomic absorption spec- 
troscopy. 
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3. RESULTS 
Iron/protein wt/wt ratios in the haemosiderins 
were 0.43 (PH) and 0.40 (SH). Peptide analysis of 
the haemosiderins by SDS-PAGE showed major 
bands of approx. 20 kDa (PH) and 15 kDa (SH). 
Although the 20 kDa band was similar to that 
observed for the ferritin peptides, the ultrastruc- 
ture of the PH-derived haemosiderin, as shown by 
electron microscopy of the unstained protein, was 
clearly different from the discrete cores of ferritin 
isolated from the same tissue. The haemosiderin 
cores were of low electron density, extensively ag- 
gregated and irregular in morphology (fig.la). In 
contrast, haemosiderin cores isolated from both 
the liver and spleen of SH patients were well- 
defined angular particles (fig. lb) which were less 
aggregated than the PH-derived material but less 
discrete than the associated ferritin cores. 
The structural nature of the haemosiderin and 
ferritin cores was determined by electron diffrac- 
tion and 57Fe Mossbauer spectroscopy. Ferritin 
cores from all the samples studied showed fer- 
rihydrite electron diffraction patterns (PH ferritin 
cores were generally less crystalline). Diffraction 
patterns of PH-derived liver haemosiderin showed 
only minimal evidence for long-range order; the 
one distinct diffraction line at 2.49 A and two 
broadened lines centred around 2.12 A and 1.53 A 
(table 1) indicated that the material was primarily 
amorphous Fe(II1) oxide with some partial order- 
ing based on the ferrihydrite structure. In contrast, 
the electron diffraction patterns of both liver and 
spleen SH haemosiderin showed eight or nine dif- 
fraction lines. Although many of these lines could 
be assigned to either ferrihydrite or goethite (cu- 
FeOOH), the diffraction lines at -4.2 and 2.7 A 
provided unequivocal evidence for the presence of 
goethite. However, some of the weaker goethite 
lines were absent, indicating that the SH 
haemosiderin was not perfectly ordered 
stoichiometric goethite but a defect micro- 
crystalline phase. 
The 57Fe Mossbauer spectra of liver PH 
haemosiderin showed a predominant central 
doublet down to 4.2 K with substantial 
magnetically split six-line components only occur- 
ring below this temperature. This spectral 
behaviour combined with the isomer shift and 
quadrupole splitting parameters at 0.50 and 
0.67 mems-‘, respectively, is characteristic of a 
magnetically disordered high spin Fe(II1) material 
and is consistent with the electron diffraction 
results. The distinct difference between the 
Mossbauer spectra of PH- and SH-derived 
haemosiderins can be seen in fig.2, which shows 
their 4.2 K spectra. The SH haemosiderin from 
both liver and spleen showed only a six-line 
magnetically ordered high spin Fe(II1) spectral 
component at this temperature compared with the 
Fig. I. Transmission electron micrographs of (a) primary haemochromatosis liver haemosiderin (mean particle size = 5.8 nm; range, 
5.36-6.31 nm) and (b) secondary haemochromatosis spleen haemosiderin (mean particle size = 5.6 nm; range, 4.33-6.50 nm). Scale 
bars = 20 nm. 
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Table 1 
Electron diffraction data (d spacings (A) and relative 
intensities) for haemosiderin isolated from iron-overloaded 
tissue 
Primary haemo- Secondary haemo- Ferritin 
chromatosis chromatosis (liver/spleen) 
in liver 
Liver Spleen 
4.13 M 4.25 M G 
2.65 M 2.68 M G 
2.49 S F 2.45 S 2.45 S G/F 2.41 S F 
2.22 s 2.20 s G/F 2.22 S F 
2.12 B F 1.97 w 1.99 w G/F 1.93MF 
1.72 S 1.71 s G/F 1.71 W F 
1.54 W G 
1.53 B F 1.49 w 1.47 w G/F 1.48 W F 
1.46 S 1.43 s G 
Intensities: S, strong; M, medium; W, weak; B, broad band. 
Assignments made on the basis of known standard d spacings; 
G, goethite; F, ferrihydrite. Data for ferritin are shown for 
comparison 
predominant doublet of the PH sample. The 
temperature dependence of the SH haemosiderin 
spectra (data not shown) was characteristic of a 
single Fe-containing phase consisting of small, 
magnetically ordered particles. This behaviour was 
qualitatively identical to that observed for the fer- 
ritin samples but the temperature at which the 
doublet and sextet components were equal in spec- 
tral intensity was approximately 65 K for the SH 
haemosiderin compared with 40 K for human fer- 
ritin [4], 28 K for horse haemosiderin [14] and 
23 K for rat haemosiderin [7]. 
Dialysis of the protein cores against oxalate gave 
the following order in decreasing solubility: PH 
haemosiderin > PH ferritin > SH ferritin > SH 
haemosiderin (fig.3). Oxalate buffer was used as it 
is a standard analytical method for the preferential 
dissolution of mineralogical ferrihydrite over 
goethite and other iron oxides [8]. Similar results 
were obtained for dissolution experiments using 
clinically important chelators such as desferriox- 
amine (O’Connell, M., unpublished data). 
The structural specificity of haemosiderin iron 
cores in PH and SH has important biochemical 
and biomedical implications. The general consen- 
sus in the literature is that haemosiderin is derived 
from ferritin by lysosomal degradation of its pro- 
tein shell. For example, both horse, normal human 
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Fig.2. 57Fe Mdssbauer spectra recorded at 4.2 K of (a) primary 
haemochromatosis liver haemosiderin and (b) secondary 
haemochromatosis liver haemosiderin. 
(Dickson, D.P.E., unpublished data) [9,14] and 
rat [7,13] haemosiderins have structures and block- 
ing temperatures consistent with ferrihydrite par- 
ticles of smaller size than ferritin cores. However, 
our results indicate that this direct relationship 
does not apply to human haemosiderin and ferritin 
cores derived from iron-overloaded tissue. PH- 
derived liver haemosiderin arises from the uptake 
and storage of iron by the hepatocytes under con- 
ditions of enhanced absorption of dietary iron. 
The disordered nature of these cores indicates 
rapid intracellular iron precipitation presumably 
due to high local iron levels; consistent with this 
hypothesis is the poorly ordered ferrihydrite cores 
of the associated liver ferritin, and the presence of 
amorphous Fe(II1) deposits in rat myocardial cells 
subjected to high iron concentrations in the growth 
media [lo]. The major peptide band at 20 kDa and 
the extensive aggregation of the cores as viewed in 
the electron microscope suggest that although the 
protein is ferritin-like it is disorganised around and 
between the mineral particles. One possibility is 
that iron uptake by the hepatocytes is at such a 
high rate that non-specific deposition takes place 
external to apoferritin resulting in extensive 
protein-mineral aggregates. 
The goethite-like structure of both liver and 
spleen SH haemosiderin cores is more ther- 
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Fig.3. Dissolution of iron from iron-storage proteins. Primary 
haemochromatosis haemosiderin and ferritin (A ,0) and 
secondary haemochromatosis haemosiderin and ferritin (A ,o), 
respectively. 
modynamically stable than the ferrihydrite cores 
of ferritin, which suggests that the formation of 
these haemosiderin complexes takes place under 
conditions of slow crystallization, for example, 
from the slow oxidation of aqueous Fe(I1) ions 
arising from low Fe(I1) and 02 concentrations, 
complexation, and low lysosomal pH. Alternative- 
ly, the slow degradation of Fe(II1) complexes could 
favour goethite precipitation. Significantly, the in 
situ phase transformation of ferritin cores is not 
possible because the structures of goethite and fer- 
rihydrite are not closely related. If ferritin is to be 
implicated, therefore, in the formation of SH 
haemosiderin it must be via chemical modification 
of the ferrihydrite cores. Since the source of iron 
in transfusional iron overload is from effete 
erythrocytes, the rate of processing of this iron by 
the reticuloendothelial (RE) system is likely to be 
relatively slow when compared with the dietary 
iron-overload of PH. Thus there is the possibility 
of normal ferritin uptake of iron followed by pro- 
tein degradation (as shown by the 15 kDa band in 
SH haemosiderin) and (partial) dissolution of the 
ferritin cores in the lysosomes of the RE cells. The 
slow reprecipitation of the soluble iron within the 
lysosomes rather than mobilization via transferrin 
may reflect the saturation of this protein in the 
iron-overloaded system. 
Finally, our results predict that the more 
crystalline goethite-like deposits of SH 
haemosiderin will be less labile than the correspon- 
ding deposits in PH and will therefore have a lower 
intrinsic toxicity as shown, for example, in the 
ability to mediate lipid peroxidation in the 
presence of ascorbate [ll]. Also, the lower 
solubility of SH haemosiderin cores implies that 
they will be less readily removed by chelation 
therapy than predicted on the basis of ferrihydrite 
models. Furthermore, the results explain the 
anomalous magnetic properties of haemosiderin 
cores isolated from patients with SH [4]. 
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